EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-13Rα2 Regulates C2C12 Myoblast Proliferation via the Akt–Cyclin D1–CDK4 Pathway

Mitsutoshi Kurosaka iD, Kazuhisa Kohda

International Journal of Molecular Sciences · 21.06.2026 · 27 (12) · 5600

DOI: 10.3390/ijms27125600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.06.2026. Verfasst von Mitsutoshi Kurosaka und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki 216-8511, Kanagawa, Japan. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Cyclin D1, Myoblasts, Cyclin-Dependent Kinase 4. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin-13 receptor α2 (IL-13Rα2) has traditionally been considered a decoy receptor; however, its cellular functions beyond the immune system remain unclear. We aimed to investigate the role of IL-13Rα2 in C2C12 myoblast proliferation and differentiation. IL-13Rα2 expression was knocked down in C2C12 cells using siRNA. Myogenic differentiation was evaluated by myosin heavy chain (MyHC) immunostaining and by quantifying the expression of myogenic regulatory and fusion-related genes. Myoblast proliferation was assessed using BrdU incorporation and cell number analyses, and signaling events induced by IL-13Rα2 knockdown were analyzed via immunoblotting and immunocytochemical analysis. IL-13Rα2 knockdown did not alter myogenic differentiation or the expression of fusion-associated genes. In contrast, IL-13Rα2 knockdown significantly increased BrdU incorporation and cell number, accompanied by increased Akt phosphorylation and decreased ERK phosphorylation. Cyclin D1 and cyclin-dependent kinase 4 (CDK4) levels were also increased. Akt inhibition abolished the enhanced proliferation and normalized Cyclin D1/CDK4 levels, whereas ERK activation did not further modify the knockdown-associated phenotype. These findings demonstrate that IL-13Rα2 negatively regulates myoblast proliferation by modulating the Akt–Cyclin D1–CDK4 signaling pathway, while being dispensable for myogenic differentiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktCyclin D1MyoblastsCyclin-Dependent Kinase 4Signal TransductionInterleukin-13 Receptor alpha2 SubunitAnimalsMiceCell ProliferationCell LineCell DifferentiationPhosphorylationMuscle Development

Stichwörter der Autor:innen

Akt signalingCyclin D1IL-13Rα2cytokine signalingmyoblast proliferationskeletal muscle

Substanzen

Proto-Oncogene Proteins c-aktCyclin D1Cyclin-Dependent Kinase 4Interleukin-13 Receptor alpha2 SubunitCdk4 protein, mouseCcnd1 protein, mouse

Autor:innen und Institutionen

  • Department of Physiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki 216-8511, Kanagawa, Japan.

ORCID-Profile: Mitsutoshi Kurosaka

Förderung

  • Japan Society for the Promotion of Science
  • JSPS KAKENHI

Zitieren

APA

Kurosaka, M., & Kohda, K. (2026). IL-13Rα2 Regulates C2C12 Myoblast Proliferation via the Akt–Cyclin D1–CDK4 Pathway. International Journal of Molecular Sciences, 27(12), 5600. https://doi.org/10.3390/ijms27125600

Vancouver

Kurosaka M, Kohda K. IL-13Rα2 Regulates C2C12 Myoblast Proliferation via the Akt–Cyclin D1–CDK4 Pathway. International Journal of Molecular Sciences. 2026;27(12):5600. doi:10.3390/ijms27125600

BibTeX
@article{Kurosaka2026,
  author = {Kurosaka, Mitsutoshi and Kohda, Kazuhisa},
  title = {IL-13Rα2 Regulates C2C12 Myoblast Proliferation via the Akt–Cyclin D1–CDK4 Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5600},
  doi = {10.3390/ijms27125600}
}
Kostenlos starten →